Home › Urogenital Cancer › Virginia
Urogenital Cancer clinical trials in Virginia
3 studies for Urogenital Cancer are looking for participants at sites in Virginia.
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Virginia Oncology Associates, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07566156Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Virginia Clinical Research, Norfolk
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 25, 2026 · NCT06800313Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site number: 404, Fairfax
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05997615From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.